Acute Diarrhoea Clinical Trial
Official title:
Acceptability and Effectiveness of Household Water Chlorination in Reducing the Prevalence of Diarrhea Among Under Five Children in Eastern Ethiopia
The Millenium development goals (MDGs) call for reducing by half the proportion of people
without sustainable access to safe drinking water. This goal was adopted in large part
because safe drinking water has been seen as critical to fighting diarrheal disease. Source
protection is considered the main intervention area to achieve this goal. However, research
worldwide that has shown that even drinking water which is safe at the source is subject to
frequent and extensive fecal contamination during collection, storage and use in the home.
This contamination is through the introduction of cups, dippers or hands, contamination by
flies, cockroaches, and rats. Even piped water supplies of adequate microbial quality can
pose infectious disease risks if they become contaminated due to unsanitary collection,
storage conditions and practices within households.
To reduce this problem, point-of-use water treatment has been advocated as a means to
substantially decrease the global burden of diarrhea and to contribute to the MDGs. However,
research indicates that there are many unanswered questions around Household water treatment
(HWT) that require small or medium scale epidemiological studies and randomized controlled
trials, especially with regard to effectiveness, acceptability and identifying suitable
target populations. Some of the most urgent questions to be resolved are:(1) How much of the
currently cited disease reduction of HWT is due to bias? (2) What is the effect of HWT on
nutritional status (weight gain and growth)?(3) At which populations should HWT be targeted?
(4) Is it acceptable and sustainable in poor communities where the risk of diarrheal disease
is high.
hypothesis: Do household water treatment with chlorine reduce diarrhea among underfive
children? hypothesis: Do household water treatment with chlorine acceptable in the
community?
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02704091 -
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults
|
Phase 4 |